Human MBL2 ELISA Kit

Key features and details

  • Specification: 96 Test
  • Sensitivity: 1.92 pg/ml (50 μl)
  • Standard Curve Range: 0.03~20 ng/ml
  • Standard Curve Gradient: 7 Points/3 Folds
  • Number of Incubations: 2
  • Sample Volume: 50 μl
  • Type: Ready-to-Use
  • Operation Duration: 75min
  • Brand:
CAT.NO. : AEH0090
RMB Please choose
RMB Please choose
Size:
96T
Trail, Bulk size or Custom requests Please contact us
Product Details
Background

Mannan binding lectin (MBL) belongs to the collectin family of innate immune defense proteins, which binds to an array of carbohydrate patterns on pathogen surfaces. Collectin family members share common structural features: a cysteine rich amino-terminal domain, a collagen-like region, an alpha -helical coiled-coil neck domain and a carboxy terminal C-type (Ca++-dependent) lectin or carbohydrate recognition domain (CRD). MBL homotrimerizes to form a structural unit joined by N-terminal disulfide bridges. These homotrimers further associates into oligomeric structures of up to 6 units. Whereas two forms of MBL proteins (MBL-1, also known as S-MBP or MBL-A and MBL-2, also known as L-MBP or MBL-C) exist in rodents and other animals, only one functional MBL protein is present in humans. Mouse MBL-2 shares about 52% and 60% amino acid sequence identity with mouse MBL-1 and human MBL, respectively.

In mouse, MBL-1 and MBL-2 are the only collectins that can activate complement via the lectin complement pathway. Serum oligomeric MBL associates with MBL-associated serine protease (MASP) proenzymes. The MBL-MASP proenzyme complex preferentially interact with sugar patterns containing mannose, glucose, L‑fucose, or N-acetyl-glucosamine present at a terminal nonreducing postion on the cell surface of various pathogens and certain tumor cells. This interaction induces pro-enzyme activation and the triggering of the complement cascade, resulting in opsonization and pathogen removal via humoral and cellular immune responses. MBL does not recognize self-components or glycoproteins from other higher animals due to the presence of terminal sialic acid or galactose that interrupts the repeating carbohydrate structures. A number of membrane receptors for MBL, including C1q phagocytic receptor (C1qRp), calreticulin (also known as C1qR), and CR1 (CD35), have been described. Interactions with these receptors may also be important in stimulating phagocytosis.

Mouse MBL-1 and MBL-2 are produced primarily in the liver and are secreted into the blood stream. In addition, mouse MBL-1 is also expressed in lung, kidney, and testis while MBL-2 is expressed in kidney, thymus, and small intestine.

Tipical Data


ng/ml

O.D.

Average

Corrected

0.00

0.0068

0.0089

0.0079

0.03

0.0184

0.0191

0.0188

0.0109

0.08

0.0431

0.0464

0.0448

0.0369

0.25

0.1218

0.1243

0.1231

0.1152

0.74

0.3541

0.3709

0.3625

0.3547

2.22

0.9895

1.0440

1.0168

1.0089

6.67

2.2540

2.3080

2.2810

2.2732

20.00

3.8100

3.8060

3.8080

3.8002

Precision

Intra-assay Precision

Inter-assay Precision

Sample Number

S1

S2

S3

S1

S2

S3

22

22

22

6

6

6

Average(pg/ml)

5558.1

1836.6

373.7

5910.8

1881.4

382.7

Standard Deviation

194.1

55.8

15.7

171.4

52.1

9.5

Coefficient of Variation(%)

3.5

3.0

4.2

2.9

2.8

2.5


Intra-assay Precision (Precision within an assay) Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.

Inter-assay Precision (Precision between assays) Three samples of known concentration were tested six times on one plate to assess intra-assay precision.

Spike Recovery
The spike recovery was evaluated by spiking 3 levels of human MBL2 into health human serum sample. The un-spiked serum was used as blank in this experiment.
The recovery ranged from 89% to 118% with an overall mean recovery of 102%.
Sample Values
Sample Matrix Sample Evaluated Range (ng/ml) Detectable (%) Mean of Detectable (ng/ml)
Serum 30 154.5-547.4 100 293.8

Serum/Plasma – Thirty samples from apparently healthy volunteers were evaluated for the presence of MBL2 in this assay. No medical histories were available for the donors.
New Products
Get in touch with AREX
Name:*
Tel/Phone:*
Company:*
Email:*
Inquiry:
Captcha*
Submitting your email information means that you are willing to receive email information from AREX regarding technology, applications, products, and events. By clicking on the 'unsubscribe' button in the email or by contacting info@arexbio.com You can unsubscribe at any time by sending an email. Regarding your data usage information, please refer to our privacy policy.
© AREX 2024. All Rights Reserved. | 浙ICP备2024113709号-3 Sitemap